Team Novo Nordisk returns to the 2023 Tour de Pologne UCI World Tour


News Image

“2023 is an important year,” said Team Novo Nordisk’ General Manager, Vassili Davidenko, “Not only for our sponsor’s anniversary, but also for ten years of our partnership and wonderful work together. We are very happy to be able to celebrate this by returning to the Tour de Pologne.”

The third wild card for the 2023 Tour de Pologne UCI World Tour has officially been assigned to Team Novo Nordisk, the world’s first all-diabetes professional cycling team, which this year is celebrating the 100th anniversary of its title sponsor Novo Nordisk.

“2023 is an important year,” said Team Novo Nordisk’ General Manager, Vassili Davidenko. “Not only for our sponsor’s anniversary, but also for the ten years of our partnership and wonderful work together with them. We are very happy to be able to celebrate this by returning to the Tour de Pologne. We thank our friends at Lang Team for giving us the opportunity to compete with the best teams in the world, while inspiring all those with diabetes and showing them that it is possible to do sport even at a high level.”

A mission that has always been received with great sensitivity by the Tour de Pologne’ organization.

“It will be special to see the guys from Team Novo Nordisk racing on Polish roads,” commented Tour de Pologne’ Director, Czesław Lang. “As I have said many times, I am convinced that cycling has great power to bring people together and spread messages. The values of this team are noble and go beyond the concept of sport and applying to daily life. I hope that the Tour de Pologne, with its international audience, can contribute to raising awareness of the great goals that can be pursued by people living with this condition. Furthermore, Team Novo Nordisk has always been racing at the Tour de Pologne in an offensive and spectacular way.”

Share article on social media or email:

Leave a Reply